Copley Acquisition terminates Ignite Proteomics business combination agreement

A planned business combination between Copley Acquisition Corp. and Ignite Proteomics was terminated by mutual agreement on Oct. 9, 2026. The termination took effect immediately under the deal’s termination provisions. Related deal documents, including support and lock-up agreements, ended at the same time. Each side agreed to cover its own expenses, with mutual releases tied to the terminated transaction. Copley has until Nov. 2, 2026 to complete a business combination, subject to extensions under its organizational documents. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Copley Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-011091), on October 13, 2026, and is solely responsible for the information contained therein. (C)